| Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes S Oikarinen, S Tauriainen, D Hober, B Lucas, A Vazeou, A Sioofy-Khojine, ... Diabetes 63 (2), 655-662, 2014 | 186 | 2014 |
| The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis L Saed, F Varse, HR Baradaran, Y Moradi, S Khateri, E Friberg, Z Khazaei, ... BMC cancer 19, 1-10, 2019 | 157 | 2019 |
| Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes AB Sioofy-Khojine, J Lehtonen, N Nurminen, OH Laitinen, S Oikarinen, ... Diabetologia 61, 1193-1202, 2018 | 114 | 2018 |
| A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates VM Stone, MM Hankaniemi, OH Laitinen, AB Sioofy-Khojine, A Lin, ... Science Advances 6 (19), eaaz2433, 2020 | 85 | 2020 |
| A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes VM Stone, MM Hankaniemi, E Svedin, A Sioofy-Khojine, S Oikarinen, ... Diabetologia 61, 476-481, 2018 | 84 | 2018 |
| Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved … M Anagandula, SJ Richardson, MS Oberste, AB Sioofy‐Khojine, H Hyöty, ... Journal of medical virology 86 (8), 1402-1411, 2014 | 57 | 2014 |
| Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice T Koho, MRL Koivunen, S Oikarinen, L Kummola, S Mäkinen, ... Antiviral research 104, 93-101, 2014 | 57 | 2014 |
| Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis Y Moradi, HR Baradaran, S Djalalinia, A Chinekesh, ME Khamseh, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13 (3), 2300-2312, 2019 | 47 | 2019 |
| Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model MM Hankaniemi, OH Laitinen, VM Stone, A Sioofy-Khojine, JAE Määttä, ... Vaccine 35 (30), 3718-3725, 2017 | 45 | 2017 |
| Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity S Hämäläinen, N Nurminen, H Ahlfors, S Oikarinen, AB Sioofy‐Khojine, ... Journal of medical virology 86 (8), 1412-1420, 2014 | 34 | 2014 |
| A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine MM Hankaniemi, VM Stone, AB Sioofy-Khojine, S Heinimäki, V Marjomäki, ... Vaccine 37 (40), 5962-5971, 2019 | 31 | 2019 |
| Bradykinin as a probable aspect in SARS-Cov-2 scenarios: is bradykinin sneaking out of our sight? SM Ghahestani, J Mahmoudi, S Hajebrahimi, AB Sioofy-Khojine, ... Iranian Journal of Allergy, Asthma and Immunology, 13-17, 2020 | 30 | 2020 |
| Coxsackievirus B vaccines prevent infection-accelerated diabetes in NOD mice and have no disease-inducing effect VM Stone, M Butrym, MM Hankaniemi, AB Sioofy-Khojine, VP Hytönen, ... Diabetes 70 (12), 2871-2878, 2021 | 29 | 2021 |
| Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes AB Sioofy-Khojine, S Oikarinen, H Honkanen, H Huhtala, JP Lehtonen, ... PLoS One 13 (9), e0201959, 2018 | 27 | 2018 |
| Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine MM Hankaniemi, VM Stone, T Andrejeff, S Heinimäki, AB Sioofy-Khojine, ... Antiviral Research 171, 104595, 2019 | 25 | 2019 |
| A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses NVV Saarinen, JE Laiho, SJ Richardson, M Zeissler, VM Stone, ... Scientific reports 8 (1), 33, 2018 | 25 | 2018 |
| Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus S Heinimäki, MM Hankaniemi, AB Sioofy-Khojine, OH Laitinen, H Hyöty, ... Vaccine 37 (51), 7509-7518, 2019 | 23 | 2019 |
| Mucosal antibodies induced by intranasal but not intramuscular immunization block norovirus GII. 4 virus-like particle receptor binding K Tamminen, M Malm, T Vesikari, V Blazevic Viral immunology 29 (5), 315-319, 2016 | 22 | 2016 |
| Genetic adaptation of coxsackievirus B1 during persistent infection in pancreatic cells A Honkimaa, B Kimura, AB Sioofy-Khojine, J Lin, J Laiho, S Oikarinen, ... Microorganisms 8 (11), 1790, 2020 | 18 | 2020 |
| Structural insight into CVB3-VLP non-adjuvanted vaccine MM Hankaniemi, MA Baikoghli, VM Stone, L Xing, O Väätäinen, ... Microorganisms 8 (9), 1287, 2020 | 18 | 2020 |
